These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against Kar PP; Srivastava A Front Immunol; 2018; 9():2213. PubMed ID: 30374343 [TBL] [Abstract][Full Text] [Related]
47. Antibodies to somatic L3 antigen not protective against Brugia malayi infection. Noordin R; Abdullah KA; Azahri NA; Ramachandran CP Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):678-81. PubMed ID: 10928359 [TBL] [Abstract][Full Text] [Related]
48. In vitro apoptotic effect on human lymphatic filarial parasite by piperidine derivatives and thymidine reversal study. Bhoj PS; Rao S; Bahekar SP; Agrawal NR; Togre NS; Sharma R; Goswami K; Chandak HS; Patil MB Parasitol Res; 2020 Jan; 119(1):165-175. PubMed ID: 31807868 [TBL] [Abstract][Full Text] [Related]
49. Identification of phosphorylcholine epitope-containing antigens in Brugia malayi and relation of serum epitope levels to infection status of jirds with brugian filariasis. Wenger JD; Forsyth KP; Kazura JW Am J Trop Med Hyg; 1988 Jan; 38(1):133-41. PubMed ID: 2449088 [TBL] [Abstract][Full Text] [Related]
50. Apoptotic impact on Brugia malayi by sulphonamido-quinoxaline: search for a novel therapeutic rationale. Bhoj PS; Ingle RG; Goswami K; Jena L; Wadher S Parasitol Res; 2018 May; 117(5):1559-1572. PubMed ID: 29568978 [TBL] [Abstract][Full Text] [Related]
51. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi. Bilsland E; Bean DM; Devaney E; Oliver SG PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604 [TBL] [Abstract][Full Text] [Related]
52. Bacterial lipid modification enhances immunoprophylaxis of filarial abundant larval transcript-2 protein in Mastomys model. Sharmila S; Christiana I; Kiran P; Reddy MV; Sankaran K; Kaliraj P Parasite Immunol; 2013 Jul; 35(7-8):201-13. PubMed ID: 23495791 [TBL] [Abstract][Full Text] [Related]
53. Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis. Dakshinamoorthy G; Munirathinam G; Stoicescu K; Reddy MV; Kalyanasundaram R PLoS One; 2013; 8(10):e77394. PubMed ID: 24146990 [TBL] [Abstract][Full Text] [Related]
54. Status of lymphatic filariasis with progression of age and gender & eradication strategies: A survey among residents of Hardoi district of Uttar Pradesh, an endemic region of North India. Saeed M; Faisal SM; Ahmad I; Kausar MA; Alam MJ; Khan S; Mustafa H Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):46-51. PubMed ID: 29642988 [TBL] [Abstract][Full Text] [Related]
55. Specificity of predominant IgG4 antibodies to adult and microfilarial stages of Brugia malayi. Kurniawan-Atmadja A; Sartono E; Partono F; Yazdanbakhsh M; Maizels R Parasite Immunol; 1998 Apr; 20(4):155-62. PubMed ID: 9618725 [TBL] [Abstract][Full Text] [Related]
56. Molecular Characterization of a Reemergent Mallawarachchi CH; Chandrasena TGAN; Withanage GP; Premarathna R; Mallawarachchi SMNSM; Gunawardane NY; Dasanayake RS; Gunarathna D; de Silva NR Biomed Res Int; 2021; 2021():9926101. PubMed ID: 34414239 [TBL] [Abstract][Full Text] [Related]
57. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach. Abdulla F; Adhikari UK; Uddin MK Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417 [TBL] [Abstract][Full Text] [Related]